QSS
HALO icon

Quantitative Systematic Strategies’s Halozyme HALO Stock Holding History

Quantitative Systematic Strategies’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,778
Closed -$362K – 672
2020
Q3 		$362K Buy
13,778
+3,119
+29% +$86.9K 0.06% 395
2020
Q2 		$286K Buy
+10,659
New +$240K 0.06% 429

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantitative Systematic Strategies's HALO Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Halozyme (HALO) in Q4 2020, closing a stake of 13,778 shares — an estimated $362K sold.

Quantitative Systematic Strategies first reported a position in HALO in Q2 2020 and held it in 2 quarters. The position peaked at $362K in Q3 2020. 342 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Halozyme position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,778 Halozyme shares in Q4 2020, an estimated $362K.
  • Quantitative Systematic Strategies first reported a position in Halozyme in Q2 2020 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Halozyme position peaked at $362K in Q3 2020.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.